Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, including corn, soybean, cotton, and canola seeds under the DEKALB, Asgrow, and Deltapine brands; and vegetable seeds, such as tomato, pepper, melon, cucumber, squash, beans, broccoli, onions, lettuce, and others under the Seminis and De Ruiter brands. It also develops biotechnology traits that assist farmers in controlling insects and weeds in corn, soybean, and cotton crops under the SmartStax, YieldGard, YieldGard VT Triple, VT Triple PRO, and VT Double PRO brands; Intacta RR2 PRO brand; Bollgard and Bollgard II brands; Roundup Ready and Roundup Ready 2 Yield brands; and Roundup Ready 2 Xtend and Bollgard II XtendFlex brands. In addition, this segment licenses a range of germplasm and trait technologies to large and small seed companies. The Agricultural Productivity segment manufactures and sells herbicides for nonselective agricultural and residential lawn and garden applications for weed control under the Roundup brand name; and herbicides for selective agricultural applications for weed control under the XtendiMax brand name. The company markets its products through distributors, independent retailers and dealers, agricultural cooperatives, plant raisers, and agents, as well as directly to farmers. It has strategic alliance with Pairwise Plants to advance agriculture research and development by using gene-editing technology. The company was formerly known as Monsanto Ag Company and changed its name to Monsanto Company in March 2000. Monsanto Company was founded in 2000 and is based in St. Louis, Missouri.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Agricultural chemicals
Sub-IndustryFertilizers & Agricultural Chemicals
SectorBasic Materials
SymbolNYSE:MON
CUSIP61166W10
Phone314-694-1000
Debt
Debt-to-Equity Ratio0.85
Current Ratio1.41
Quick Ratio0.85
Price-To-Earnings
Trailing P/E Ratio23.26
Forward P/E Ratio22.45
P/E Growth2.64
Sales & Book Value
Annual Sales$14.64 billion
Price / Sales3.85
Cash Flow$7.2616 per share
Price / Cash17.62
Book Value$14.70 per share
Price / Book8.70
Profitability
EPS (Most Recent Fiscal Year)$5.50
Net Income$2.26 billion
Net Margins17.07%
Return on Equity37.31%
Return on Assets11.49%
Miscellaneous
Employees23,300
Outstanding Shares440,800,000
Market Cap$56,400.46
Monsanto (NYSE:MON) Frequently Asked Questions
What is Monsanto's stock symbol?
Monsanto trades on the New York Stock Exchange (NYSE) under the ticker symbol "MON."
How often does Monsanto pay dividends? What is the dividend yield for Monsanto?
Monsanto announced a quarterly dividend on Wednesday, January 31st. Investors of record on Friday, April 6th will be given a dividend of $0.54 per share on Friday, April 27th. This represents a $2.16 annualized dividend and a dividend yield of 1.69%. The ex-dividend date of this dividend is Thursday, April 5th. View Monsanto's Dividend History.
How were Monsanto's earnings last quarter?
Monsanto (NYSE:MON) issued its earnings results on Wednesday, October, 4th. The basic materials company reported $0.20 EPS for the quarter, beating the consensus estimate of ($0.41) by $0.61. The basic materials company had revenue of $2.69 billion for the quarter, compared to analysts' expectations of $2.51 billion. Monsanto had a net margin of 17.07% and a return on equity of 37.31%. Monsanto's revenue for the quarter was up 4.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.07 EPS. View Monsanto's Earnings History.
What price target have analysts set for MON?
11 Wall Street analysts have issued 1-year price objectives for Monsanto's stock. Their predictions range from $119.00 to $128.00. On average, they expect Monsanto's stock price to reach $126.3750 in the next year. This suggests that the stock has a possible downside of 1.2%. View Analyst Ratings for Monsanto.
What is the consensus analysts' recommendation for Monsanto?
11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Monsanto in the last year. There are currently 1 sell rating, 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
Who are some of Monsanto's key competitors?
Some companies that are related to Monsanto include Nutrien (NTR), Mosaic (MOS), CF Industries (CF), Israel Chemicals (ICL), Scotts Miracle-Gro (SMG), Nufarm (NUF), Terra Nitrogen (TNH), American Vanguard (AVD), Calyxt (CLXT), CVR Partners (UAN), Marrone Bio Innovations (MBII), Wynnstay Group (WYN), Evogene (EVGN), China Green Agriculture (CGA) and SenesTech (SNES).
Who are Monsanto's key executives?
Monsanto's management team includes the folowing people:
- Mr. Hugh Grant, Exec. Chairman & CEO (Age 60)
- Mr. Brett D. Begemann, Pres & COO (Age 57)
- Mr. Pierre C. Courduroux, Sr. VP & CFO (Age 53)
- Dr. Robert T. Fraley Ph.D., Exec. VP & CTO (Age 65)
- Mr. David F. Snively, Exec. VP, Sec. & Gen. Counsel (Age 64)
Has Monsanto been receiving favorable news coverage?
Press coverage about MON stock has been trending somewhat positive on Sunday, Accern Sentiment reports. The research firm ranks the sentiment of news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Monsanto earned a coverage optimism score of 0.04 on Accern's scale. They also assigned headlines about the basic materials company an impact score of 45.72 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
Who are Monsanto's major shareholders?
Monsanto's stock is owned by many different of retail and institutional investors. Top institutional investors include Whittier Trust Co. (0.00%) and Whittier Trust Co. of Nevada Inc. (0.00%). Company insiders that own Monsanto stock include Andrew Thomson, Brett D Begemann, Charles S Mcmillan, Duraiswami Narain, Hugh Grant, Janet M Holloway, Kerry J Preete, Michael K Stern, Nicole M Ringenberg, Pierre Courduroux, Robert T Fraley and Steven Mizell. View Institutional Ownership Trends for Monsanto.
Which major investors are selling Monsanto stock?
MON stock was sold by a variety of institutional investors in the last quarter, including Whittier Trust Co. of Nevada Inc. and Whittier Trust Co.. Company insiders that have sold Monsanto company stock in the last year include Brett D Begemann, Duraiswami Narain, Nicole M Ringenberg, Pierre Courduroux and Steven Mizell. View Insider Buying and Selling for Monsanto.
How do I buy shares of Monsanto?
Shares of MON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Monsanto's stock price today?
One share of MON stock can currently be purchased for approximately $127.95.
How big of a company is Monsanto?
Monsanto has a market capitalization of $56.40 billion and generates $14.64 billion in revenue each year. The basic materials company earns $2.26 billion in net income (profit) each year or $5.50 on an earnings per share basis. Monsanto employs 23,300 workers across the globe.
How can I contact Monsanto?
Monsanto's mailing address is 800 NORTH LINDBERGH BLVD, ST LOUIS MO, 63167. The basic materials company can be reached via phone at 314-694-1000 or via email at [email protected]
MarketBeat Community Rating for Monsanto (NYSE MON)
MarketBeat's community ratings are surveys of what our community members think about Monsanto and other stocks. Vote "Outperform" if you believe MON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MON will underperform the S&P 500 over the long term. You may vote once every thirty days.
